Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases
Clinical trial NCT06440746 · RECRUITING
Trial details
- NCT number
- NCT06440746
- Sponsor
- R-Pharm International, LLC
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-23
- Primary completion
- 2027-04-09
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.